Virax Biolabs Group Limited (VRAX)

$0.59 0.00 (-0.83%)
Market Cap 2.54M
Revenue (ttm) 10,000.00
Net Income (ttm) -6.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -60,600.00%
Debt to Equity Ratio 0.01
Volume 89,300
Avg Vol 743,888
Day's Range N/A - N/A
Shares Out 4.34M
Stochastic %K 4%
Beta 1.64
Analysts Sell
Price Target $3.00

Company Profile

Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 20 7788 7414
Address:
BioCity Glasgow, Bo’Ness Road Newhouse, Lanarkshire, United Kingdom
invinc1ble
invinc1ble Oct. 25 at 3:33 PM
$VRAX buy zone. can surprise you
0 · Reply
Paulfrench
Paulfrench Oct. 20 at 9:40 PM
$VRAX Many people look depressed on this board 😱🥴, but today's candlestick just sent us a powerful bullish signal🤤. Price breaks through 3 major resistance lines without any effort...I'm betting on a return to $0.62 tomorrow and then🚀
1 · Reply
ucla44life
ucla44life Oct. 16 at 9:07 PM
$VRAX got suckered again by MM's lower, lower, lower inbound...can't wait for trips, dilution, reverse split... WILL NEVER MAKE NASDAQ COMPLIANCE!!! Whomp, Whomp...losers gonna lose weeeeeeeeeee
0 · Reply
Slitherin
Slitherin Oct. 16 at 7:45 PM
RMSG can 3X with the tiny 1M float. Shorts are trapped which will ignite a mother of all short squeezes. $PRAX $OPEN $IVF $NIVF $VRAX WW
0 · Reply
TrdrBuckNKy
TrdrBuckNKy Oct. 16 at 7:16 PM
$VRAX ...like I said...
1 · Reply
TrdrBuckNKy
TrdrBuckNKy Oct. 16 at 10:47 AM
$VRAX It Will Happen
0 · Reply
Camaro12
Camaro12 Oct. 14 at 3:21 PM
$VRAX best thing I did was take my L and move on luckily I made it back up elsewhere!
1 · Reply
FreddieMercury91
FreddieMercury91 Oct. 13 at 2:20 PM
$VRAX loser stock
0 · Reply
TrdrBuckNKy
TrdrBuckNKy Oct. 9 at 4:38 PM
$VRAX ...DRUG - April 29th, 2024 .93 cents 1 year ago today, around $1.14 10/18/24 it hit $79.42,...similarities between DRUG and VRAX perhaps?...check their FDA history...possibly something there/here...?
0 · Reply
Void2Trade
Void2Trade Oct. 8 at 8:23 PM
$VRAX
0 · Reply
Latest News on VRAX
Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Aug 26, 2025, 7:30 AM EDT - 2 months ago

Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Jul 29, 2025, 7:35 AM EDT - 3 months ago

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Jul 18, 2025, 4:15 PM EDT - 3 months ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Mar 31, 2025, 2:57 PM EDT - 7 months ago

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Mar 18, 2025, 7:30 AM EDT - 7 months ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Mar 13, 2025, 7:30 AM EDT - 8 months ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Mar 5, 2025, 7:30 AM EST - 8 months ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Feb 25, 2025, 7:00 AM EST - 8 months ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Jan 23, 2025, 3:35 PM EST - 9 months ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

COSM

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Jan 13, 2025, 9:20 AM EST - 10 months ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

COSM

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dec 17, 2024, 7:30 AM EST - 11 months ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Dec 10, 2024, 7:30 AM EST - 11 months ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Oct 23, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

COSM

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Sep 16, 2024, 8:30 AM EDT - 1 year ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

COSM

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Virax Biolabs to Participate at 7th European Congress of Immunology

Aug 29, 2024, 9:03 AM EDT - 1 year ago

Virax Biolabs to Participate at 7th European Congress of Immunology

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Aug 28, 2024, 2:18 PM EDT - 1 year ago

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Aug 28, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Aug 23, 2024, 4:09 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 9:30 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

Aug 21, 2024, 10:20 AM EDT - 1 year ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

COSM

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Apr 25, 2024, 8:00 AM EDT - 1 year ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Virax Biolabs to Participate at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs to Participate at ESCMID Global 2024

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 21, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Dec 14, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 12, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Sep 1, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Jul 18, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

May 4, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Apr 19, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 10, 2023, 5:17 PM EST - 2 years ago

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 8, 2023, 8:55 AM EST - 2 years ago

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Mar 7, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

Feb 7, 2023, 9:15 AM EST - 2 years ago

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

COSM

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

Feb 7, 2023, 8:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

COSM

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Feb 6, 2023, 4:05 PM EST - 2 years ago

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

Jan 4, 2023, 7:30 AM EST - 3 years ago

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Dec 6, 2022, 7:30 AM EST - 3 years ago

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Nov 15, 2022, 7:30 AM EST - 3 years ago

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Nov 8, 2022, 4:30 PM EST - 3 years ago

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

Nov 4, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Nov 3, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Oct 26, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

Sep 22, 2022, 8:07 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

COSM

Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

Sep 12, 2022, 7:00 AM EDT - 3 years ago

Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

Sep 6, 2022, 4:00 PM EDT - 3 years ago

Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

Aug 16, 2022, 7:31 AM EDT - 3 years ago

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

Jul 26, 2022, 8:00 AM EDT - 3 years ago

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

invinc1ble
invinc1ble Oct. 25 at 3:33 PM
$VRAX buy zone. can surprise you
0 · Reply
Paulfrench
Paulfrench Oct. 20 at 9:40 PM
$VRAX Many people look depressed on this board 😱🥴, but today's candlestick just sent us a powerful bullish signal🤤. Price breaks through 3 major resistance lines without any effort...I'm betting on a return to $0.62 tomorrow and then🚀
1 · Reply
ucla44life
ucla44life Oct. 16 at 9:07 PM
$VRAX got suckered again by MM's lower, lower, lower inbound...can't wait for trips, dilution, reverse split... WILL NEVER MAKE NASDAQ COMPLIANCE!!! Whomp, Whomp...losers gonna lose weeeeeeeeeee
0 · Reply
Slitherin
Slitherin Oct. 16 at 7:45 PM
RMSG can 3X with the tiny 1M float. Shorts are trapped which will ignite a mother of all short squeezes. $PRAX $OPEN $IVF $NIVF $VRAX WW
0 · Reply
TrdrBuckNKy
TrdrBuckNKy Oct. 16 at 7:16 PM
$VRAX ...like I said...
1 · Reply
TrdrBuckNKy
TrdrBuckNKy Oct. 16 at 10:47 AM
$VRAX It Will Happen
0 · Reply
Camaro12
Camaro12 Oct. 14 at 3:21 PM
$VRAX best thing I did was take my L and move on luckily I made it back up elsewhere!
1 · Reply
FreddieMercury91
FreddieMercury91 Oct. 13 at 2:20 PM
$VRAX loser stock
0 · Reply
TrdrBuckNKy
TrdrBuckNKy Oct. 9 at 4:38 PM
$VRAX ...DRUG - April 29th, 2024 .93 cents 1 year ago today, around $1.14 10/18/24 it hit $79.42,...similarities between DRUG and VRAX perhaps?...check their FDA history...possibly something there/here...?
0 · Reply
Void2Trade
Void2Trade Oct. 8 at 8:23 PM
$VRAX
0 · Reply
ucla44life
ucla44life Oct. 8 at 5:03 PM
$VRAX SCAM
1 · Reply
sophrogeny
sophrogeny Oct. 8 at 2:36 PM
$VRAX tokyo wellness check...
1 · Reply
nemo11182
nemo11182 Oct. 8 at 1:36 PM
$VRAX i regret buying this. think itll ever do anything? lol i sold pltr to buy then then pltr doubled and this went fractional
0 · Reply
TrdrBuckNKy
TrdrBuckNKy Oct. 6 at 6:22 PM
$VRAX FDA...on the move...SAN FRANCISCO, Calif. --(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to tralesinidase alfa enzyme replacement therapy (TA-ERT) for the treatment of Sanfilippo Syndrome Type B (MPS IIIB).
0 · Reply
LoveNvidia
LoveNvidia Oct. 3 at 2:41 AM
Looks like volume & momentum could be shifting in to ASTC! Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $BURU $CDIO $RDHL $SPRB $VRAX 22
0 · Reply
ucla44life
ucla44life Sep. 29 at 6:28 PM
$VRAX LOWER, LOWER, LOWER ON THIS SCAM...DON'T GET CAUGHT HOLDING THE BAG LIKE ALL THE OTHER LOSERS OVER THE PAST YEAR....CHART STRAIGHT DOWN FROM $4+ FOR A REASON DURRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRR
0 · Reply
ucla44life
ucla44life Sep. 29 at 5:56 PM
$VRAX STINKY PINKY ALERT - SCAM, SCAM, SCAM!
0 · Reply
ucla44life
ucla44life Sep. 29 at 3:22 PM
$VRAX these bag holders about to get ruined with the next step lower, then lower, then lower....THE SCAM THAT KEEPS ON SCAMMING...not one can even give a reason why they're bullish....you know why? BECAUSE THERE IS NONE!!! ABSOLUTE TRASH RUN BY A CON-ARTIST
0 · Reply
RAFN
RAFN Sep. 27 at 12:04 AM
$PSTV $ENVB $SONM $VRAX 0.60
0 · Reply
ucla44life
ucla44life Sep. 26 at 5:30 PM
$VRAX Poo-Poo
0 · Reply
BUYdontCRY
BUYdontCRY Sep. 26 at 12:35 PM
$VRAX saw some loading this one last few weeks. .90 cash per share and only a 4M float with 10% short. Meeting with FDA “early September” well it’s almost over now…. Give me $1.20
1 · Reply
ucla44life
ucla44life Sep. 25 at 3:39 PM
$VRAX Next leg down incoming and all the new bag holders going to wonder why....THIS IS A SCAM durrrrrrrrrrrrrrrrrrrrr This never-ending cycle of crushing people just won't stop...from $4+ straight down to pennies....going to be epic when the inevitable trips comes or reverse split and all these losers are left with nothing. Couple months more before Nasdaq pulls the plug as compliance isn't met weeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee WHAT AN ABSOLUTE SCAM RUN BY A CON-ARTIST!!! crazy how people don't listen or see the FACTS!!! oh well, YOU LOSE WHOMP, WHOMP!!!
0 · Reply